XML 65 R41.htm IDEA: XBRL DOCUMENT v3.23.3
SHARE-BASED AWARDS (Tables)
12 Months Ended
Jul. 29, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-based Compensation Arrangements by Share-based Payment Award
The following table presents information regarding share-based compensation expenses and the related tax impacts:
(in millions)202320222021
Restricted stock awards$35 $36 $36 
Supervalu replacement awards(1)
— — 
Performance-based share awards
Share-based compensation expense recorded in Operating expenses38 43 49 
Income tax benefit(10)(12)(13)
Share-based compensation expense, net of tax$28 $31 $36 
Share-based compensation expense recorded in Restructuring, acquisition and integration related expenses(2)
$— $$
Income tax benefit— — — 
Share-based compensation expense recorded in Restructuring, acquisition and integration related expenses, net of tax$— $$
(1)Amounts are derived primarily from liability classified awards.
(2)Includes equity classified awards of $1 million for fiscal 2022 and fiscal 2021, respectively.
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity
The fair value of restricted stock units and performance share units are determined based on the number of units granted and the quoted price of the Company’s common stock as of the grant date. The following summary presents information regarding restricted stock units, Supervalu Replacement Awards and performance share units:
Number
of Shares
(in millions)
Weighted Average
Grant-Date
Fair Value
Outstanding at August 1, 20207.4 $18.54 
Granted2.4 17.55 
Vested(2.6)19.94 
Forfeited/Canceled(0.4)24.11 
Outstanding at July 31, 20216.8 17.33 
Granted1.2 45.46 
Vested(2.8)42.06 
Forfeited/Canceled(0.3)37.68 
Outstanding at July 30, 20224.9 20.02 
Granted1.7 35.01 
Vested(3.1)35.48 
Forfeited/Canceled(0.3)21.55 
Outstanding at July 29, 20233.2 $32.11 

(in millions)202320222021
Intrinsic value of restricted stock units vested$113 $125 $51 
Schedule of Share-based Compensation, Stock Options, Activity The following summary presents information regarding outstanding stock options as of July 29, 2023 and changes during the fiscal year then ended:
Number
of Options
(in millions)
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Term
Aggregate
Intrinsic
Value
Outstanding at beginning of year0.5 $54.11 
1.6 years
Exercised— 37.02   
Canceled(0.2)52.08   
Outstanding at end of year0.3 — 
1.1 years
$— 
Exercisable at end of year0.3 $55.46 
1.1 years
$—